Cardinal Health Gets a Hold Rating from Robert W. Baird

By Jason Carr

In a report issued on September 13, Eric Coldwell from Robert W. Baird reiterated a Hold rating on Cardinal Health (NYSE: CAH), with a price target of $73. The company’s shares closed on Friday at $67.50.

According to, Coldwell is a 4-star analyst with an average return of 7.2% and a 55.2% success rate. Coldwell covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Walgreens Boots Alliance, and Quintiles Transnational.

Currently, the analyst consensus on Cardinal Health is Moderate Buy and the average price target is $77, representing a 14.1% upside.

In a report issued on August 29, Jefferies also reiterated a Hold rating on the stock with a $77 price target.

The company has a one year high of $84.88 and a one year low of $62.70. Currently, Cardinal Health has an average volume of 2.11M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Cardinal Health, Inc. is a healthcare services company providing pharmaceutical and medical products. It operates through the Pharmaceutical and Medical segments.